Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
Sana Biotechnology has raised $69.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
Sana Biotechnology's investors include RA Capital Management, ARCH Venture Partners, Mayo Clinic, Omega Funds, Google Ventures.
Sana Biotechnology is headquartered in Seattle, United States.
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
Sana Biotechnology is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sana Biotechnology — Funding & Investors." VCBacked, May 15, 2026, https://www.vcbacked.co/company/sana-biotechnology. Accessed September 30, 2026.
VCBacked. (2026). Sana Biotechnology — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/sana-biotechnology
{{cite web |title=Sana Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/sana-biotechnology |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated